{"name":"NantHealth","slug":"nanthealth","ticker":"NH","exchange":"NASDAQ","domain":"nanthealth.com","description":"NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.","hq":"Culver City, CA","founded":0,"employees":"","ceo":"Ron Louks","sector":"Precision Medicine / Health IT","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$145M","metrics":{"revenue":67002000,"revenueGrowth":6.9,"grossMargin":0,"rdSpend":23047000,"netIncome":-67779000,"cash":159551000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"NantOmics patent cliff ($0.0B at risk)","drug":"NantOmics","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"NantHealth Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"NantHealth reported its financial results for the fourth quarter and full year 2023, with revenue of $44.6 million and a net loss of $34.6 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"NantHealth Announces Collaboration with IBM Watson Health","summary":"NantHealth announced a collaboration with IBM Watson Health to develop a new AI-powered platform for cancer diagnosis and treatment.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"NantHealth Receives FDA Clearance for Its Genomic Medicine Platform","summary":"NantHealth received FDA clearance for its Genomic Medicine Platform, which is designed to help healthcare providers make more informed treatment decisions.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2024-02-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-01-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-12-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-11-22","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2023-11-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-10-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-09-26","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SC 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPYURpWml3QW84YzBNZURaUUpQLVRFOThMbjB0X2FkVjhFQXhxNmN6cWJNclAzRHdHSUZMWi1XVUNhekpNemdrMTRWZktEeC1ETjUwMG1xUWVhRDdoYk1aLXgwTFB1Yk5SdWE1Zk4yODFrdTN1ZWVENUJfYm1XeTVWUFBRT0hLOGRjX3BFUEFock9vMXBucDFnOEtsSjZOYXh6d292ZG9qTQ?oc=5","date":"2016-10-27","type":"pipeline","source":"Fierce Biotech","summary":"NantHealth scores reimbursement for cancer testing service - Fierce Biotech","headline":"NantHealth scores reimbursement for cancer testing service","sentiment":"neutral"}],"patents":[{"drugName":"NantOmics","drugSlug":"nantomics","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Foundation Medicine","Invitae","Exact Sciences"],"therapeuticFocus":["Oncology","Precision Medicine"],"financials":{"source":"sec_edgar+yahoo","revenue":67002000,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":67002000,"period":"2022-12-31"},{"value":62649000,"period":"2021-12-31"},{"value":62649000,"period":"2021-12-31"},{"value":73172000,"period":"2020-12-31"},{"value":73172000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":23047000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-67779000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":159551000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}